Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.24.1.1.u2
Cover - shares
 3 Months Ended
Mar. 31, 2024
May 14, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name PASITHEA THERAPEUTICS CORP.  
Entity Central Index Key 0001841330  
Entity File Number 001-40804  
Entity Tax Identification Number 85-1591963  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 1111 Lincoln Road  
Entity Address, Address Line Two Suite 500  
Entity Address, City or Town Miami Beach  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33139  
Entity Phone Fax Numbers [Line Items]    
City Area Code (702)  
Local Phone Number 514-4174  
Entity Listings [Line Items]    
Entity Common Stock, Shares Outstanding   1,043,248
Common Stock, par value $0.0001 per share    
Entity Listings [Line Items]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol KTTA  
Security Exchange Name NASDAQ  
Warrants, to purchase shares of Common Stock, par value $0.0001 per share    
Entity Listings [Line Items]    
Title of 12(b) Security Warrants, to purchase shares of Common Stock, par value $0.0001 per share  
Trading Symbol KTTAW  
Security Exchange Name NASDAQ